Managed by NetworkPharma

Managed by

Facilitating Networking and Information Sharing amongst Pharmaceutical and MedComms, Medical Communications, Medical Education and Medical Publishing Specialists

This global initiative facilitates networking and dialogue amongst individuals working in and around the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities.
Why not sign up to our weekly newsletter and please, help spread the word amongst all relevant others.


  • Home
  • About us
  • Testimonials
  • Events
  • Useful Reading
  • In the News
  • Companies
  • Independents
  • Services
  • Special offers
  • Job Adverts
  • Twittering
  • Webcasts
  • Starting out
  • Weekly Newsletter
  • Weekly Comment
  • Survey data
  • Sponsors

  • MedComms Networking on Facebook

    MedComms Networking on Linkedin

    MedComms Networking on Twitter

    MedComms Networking on YouTube

    MedComms Networking is sponsored by:

    Many thanks to all the Sponsors of MedComms Networking


    Every Tuesday we send out the MedComms Networking email newsletter to subscribers. It includes brief commentary on what we're doing and planning, and highlights relevant news to encourage sharing of information, experiences and ideas and to stimulate discussion. The text and links included below, by definition, were accurate on the day of publication, but may then become outdated.

    MedComms Networking - 20 February 2018


    So, Ben Goldacre's new tool, the FDAAA TrialsTracker, was launched yesterday amid another torrent of tweets. Unless I'm missing the point, it currently shows us that 94.2 percent of relevant trials were reported correctly and in timely fashion on and, so far, no pharmaceutical industry funded trials are missing... I know, it's early days (well, very early days!) but it does seem to me that in here somewhere we're seeing some positive industry news and that maybe as a community we could/should shout a little louder sometimes about what we're achieving. I'm still surprised that so little industry attention was given to the publication at the turn of the year of the ABPI-sponsored study, Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2014. What did I miss? I quote;

    "The disclosure rate within 12 months of 93% suggests that industry is continuing to achieve disclosure in a timely manner. The overall disclosure rate at study end of 96% indicates that the improvement in transparency amongst company-sponsored trials has been maintained in the trials associated with new medicines approved in 2014."

    Or how about this very quotable quote, from last week's BMJ Open in Characteristics and publication fate of unregistered and retrospectively registered clinical trials submitted to The BMJ over 4 years;

    "The problem of deficient trial registration is almost entirely confined to government, foundation and academically funded studies."

    Anyway, you can read Ben's preprint here, FDAAA TrialsTracker: A live informatics tool to monitor compliance with FDA requirements to report clinical trial results and here is the Open Letter from Ben and the AllTrials team to the Commissioner at the FDA.

    I'm looking forward to daily updates.

    Meanwhile if you're new to MedComms - or manage someone who is - you might be interested in the next Pharmaceutical Landscape Training Day, in Macclesfield on 8 March led by Adrian Brown. Previous events in Oxford and Macclesfield worked really well. The programme was developed in consultation with the Sponsors of MedComms Networking and is pitched at new starters in their first 12 months, probably earlier on than later.

    Finally, a quick word about the upcoming - 10th - edition of our original MedComms Careers Guide, which will be published in March. It's a bumper issue with more agencies involved than ever before. I have a little space left if you'd like your agency in it but I need to know quickly now. This isn't about short term recruitment needs, it's about the wider objective of championing this MedComms business of ours to as wide an audience as possible, and attracting more great talent in. Over 10 years I reckon we've made some useful progress.

    Have a great week, everyone. By the way, more than 150 individuals have now registered to attend next week's 3rd #medcomms virtual event - Digital features in medical publications: Where are we now? Join us, and bring friends. And cake. Lots of cake!


    Peter Llewellyn
    Managing Director, NetworkPharma Ltd
    Follow me on Twitter @NetworkPharma
    Join 4,000 international colleagues in the MedComms Networking Linkedin Group
    The information at is always bang up-to-date!


    Subscribe to the weekly MedComms Networking email newsletter here - it's entirely free of charge!

    This web site and associated activities are being managed by NetworkPharma Ltd, Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, UK
    Telephone +44 (0) 1865 784390 Email:

    Our web sites

    [] [] [] []
    [] [] []
    [] [] []